Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failure
- 1 October 1984
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 6 (4) , 445-456
- https://doi.org/10.1016/0167-5273(84)90324-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.Heart, 1983
- Association of hyponatremia with increased renin activity in chronic congestive heart failure: Impact of diuretic therapyThe American Journal of Cardiology, 1983
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Potentiation of bradykinin by captopril during suppression of prostacyclin synthesis.Hypertension, 1982
- RENAL GLYCOSURIA AND AZOTAEMIA AFTER ENALAPRIL MALEATE (MK-421)The Lancet, 1982
- Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captoprilThe American Journal of Cardiology, 1982
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981
- Progress in Vasodilator Therapy for Heart FailureNew England Journal of Medicine, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met-enkephalinBiochemical and Biophysical Research Communications, 1979